Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Multi-Center Phase II Study to Compare MER-101 20mg Tablets to Intravenous Zometa 4mg in Male Bisphosphonate-Naive, Hormone Refractory Prostate Cancer Patients
Phase 2
Completed
- Conditions
- Hormone-Refractory Prostate Cancer
- Interventions
- Drug: Zoledronic Acid 20mg Tablets
- First Posted Date
- 2008-03-14
- Last Posted Date
- 2009-02-20
- Lead Sponsor
- Merrion Pharmaceuticals, LLC
- Target Recruit Count
- 30
- Registration Number
- NCT00636740
- Locations
- 🇺🇸
Birmingham Hematology & Oncology Associates, LLC, Birmingham, Alabama, United States
🇺🇸Cancer Care of North Florida, P.A., Lake City, Florida, United States
🇺🇸Lakeland Regional Cancer Center, Lakeland, Florida, United States
News
No news found